Nifuroxazide rescues the deleterious effects due to CHCHD10 -associated MICOS defects in disease models - CNRS - Centre national de la recherche scientifique
Article Dans Une Revue Brain - A Journal of Neurology Année : 2024

Nifuroxazide rescues the deleterious effects due to CHCHD10 -associated MICOS defects in disease models

Blandine Madji Hounoum
  • Fonction : Auteur
Marc-Alexandre D’elia
  • Fonction : Auteur
Manuel Schiff

Résumé

Abstract The identification of a point mutation (p.Ser59Leu) in the CHCHD10 gene was the first genetic evidence that mitochondrial dysfunction can trigger motor neuron disease. Since then, we have shown that this mutation leads to the disorganization of the MItochondrial contact site and Cristae Organizing System (MICOS) complex that maintains the mitochondrial cristae structure. Here, we generated yeast mutant strains mimicking MICOS instability and used them to test the ability of more than 1600 compounds from 2 repurposed libraries to rescue the growth defect of those cells. Among the hits identified, we selected nifuroxazide, a broad-spectrum antibacterial molecule. We show that nifuroxazide rescues mitochondrial network fragmentation and cristae abnormalities in CHCHD10S59L/+ patient fibroblasts. This molecule also decreases caspase-dependent death of human CHCHD10S59L/+ iPSC-derived motor neurons. Its benefits involve KIF5B-mediated mitochondrial transport enhancement, evidenced by increased axonal movement and syntaphilin degradation in patient-derived motor neurons. Our findings strengthen the MICOS-mitochondrial transport connection. Nifuroxazide and analogues emerge as potential therapeutics for MICOS-related disorders like motor neuron disease. Its impact on syntaphilin hints at broader neurological disorder applicability for nifuroxazide.
Fichier sous embargo
Fichier sous embargo
0 5 11
Année Mois Jours
Avant la publication
mercredi 30 avril 2025
Fichier sous embargo
mercredi 30 avril 2025
Connectez-vous pour demander l'accès au fichier

Dates et versions

hal-04787759 , version 1 (18-11-2024)

Identifiants

Citer

Baptiste Ropert, Sylvie Bannwarth, Emmanuelle C Genin, Loan Vaillant-Beuchot, Sandra Lacas-Gervais, et al.. Nifuroxazide rescues the deleterious effects due to CHCHD10 -associated MICOS defects in disease models. Brain - A Journal of Neurology , 2024, ⟨10.1093/brain/awae348⟩. ⟨hal-04787759⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More